Changes of Immunoreactive β-Endorphin in Plasma, Pituitary and Hypothalamus of Rats during Oxygen-Induced Convulsions

We observed for the first time the differences of immunoreactive β-endorphin(IR -β- EP) content in plasma, pituitary and hypothalamus of rats under various conditionsusing radioimmunoassay (RIA) and the effects of naloxone and β - endorphin (β- EP) antiserumon initial time of convulsions (ITC), severity of convulsions(SOC) and mortality on surface(MOS) of rats to hyperbaric oxygen(HBO). The results suggest thatβ- EP may partici-pate in the course of oxygen - induced convulsions and be one of endogenous convulsion - causingagents.

Effects of plasma β-endorphin on hemorrhagic shock in acute hypoxic rats

Forty rots were randomized into 2 groups and naloxone or saline were injected to therats after they were inflicted with hemorrhagic shock at sea level and at a simulated altitude of4000m respectively to observe the effects of naloxone on left ventricular systolic pressure(LVSP),left ventricular diastolic pressure(LVDP),the maximal changing rate of LVSP(dp/dt max),heartrate(HR),and survival time of the animals.Plasma β-endorphin(β-EP)was determined beforeand after hemorrhage to observe the relationship between β-EP and hemorrhagic shock.It wasfound that the circulatory parameters of hemorrhagic shock changed more markedly at high alti-tude than at sea level,naloxone could restore these parameters and prolong the survival time inboth the animals of the sea level and high altitude groups,and plasma β-EP level was elevatedafter hemorrhage especially in those animals at high altitude.These findings indicate:(1)Hemorrhagic shock at high altitude is usually accompanied with severe clinical manifestations,rapid progression,and high mortality.(2)β-EP seems to participate in the pathologicalmanifestafions of hemorrhagic shock at high altitude,and its depressive action on myocardialcontraction may be one of the factors inducing hemorrhagic shock.(3)Naloxone possesses defi-nite property to comet hemorrhagic shock at high altitude.

Changes in beta-endorphin neuron numbers and serum hormone levels in the arcuate nucleus of ovariectomized rats undergoing treadmill exercise

BACKGROUND： The arcuate nucleus, when damaged in young rats, can lead to pathological changes in adults, such as osteoporosis. Ovariectomized rats suffer from osteoporosis at eight weeks following surgery and the number of β -endorphin immunoreactive neurons in the arcuate nucleus of the hypothalamus is significantly decreased. OBJECTIVE： To establish a rat model of osteoporosis using ovariectomy and to explore changes in the number of β-endorphin neurons and to correlate any such change with serum hormone levels in response to exercise or rest. DESIGN, TIME AND SETTING： The completely randomized block design, neural morphology study was performed at the Key Laboratory of Physiology, Guangdong Medical College, China between March 2004 and January 2005. MATERIALS： Sixteen healthy female rats were selected for ovariectomy. METHODS： Following model establishment, rats were assigned to either rest or exercise groups and each rat was housed individually. Rats in the exercise group underwent an exercise regimen using a treadmill. MAIN OUTCOME MEASURES： Eight weeks following exercise, radioimmunoassay was performed to detect serum growth hormone, estrogen and osteocalcin levels. Immunohistochemistry was used to measure changes in the number of β -endorphin neurons in the arcuate nucleus of the hypothalamus. Changes in bone metabolism were assessed using bone histomorphometry. RESULTS： In the exercise group, the β -endorphin immunoreactive neurons were high in number, darkly stained, and the nucleus was not obvious. In the rest group, the β -endorphin immunoreactive neurons were low in number and lightly stained. The number of β-endorphin immunoreactive neurons in the exercise group was higher compared with the rest group （t = 2.83, P 〈 0.05）. Estrogen levels were similar between the rest and exercise groups （P 〉 0.05）. Serum osteocalcin and growth hormone levels were significantly higher in the exercise group compared with the rest group （t = 2.78, 2.32, P 〈 0.05）. Compared with the rest group, the percentage of trabecular bone area, trabecular thickness, and trabecular number were significantly increased, but trabecular separation was significantly reduced （t=2.48, 2.57, 2.32, 3.06, P 〈 0.05） in the exercise group. In the exercise group, the trabeculae of the tibia were arranged regularly and were high in number. In the rest group, the trabeculae of the tibia were organized in a disorderly manner and were low in number, with many fat particles. CONCLUSION： Exercise promotes bone growth and delays osteoporosis by inducing an increase in the number of β-endorphin immunoreactive neurons in the arcuate nucleus of the hypothalamus and by increasing serum growth hormone and osteocalcin levels.

EFFECTS OF β-ENDORPHIN ON PHYTOHEMAGGLUTININ-INDUCED LYMPHOCYTE PROLIFERATION AND MOUSE PLAQUE-FORMING CELL RESPONSE VIA AN OPIOID RECEPTOR MECHANISM

The effects of opioid peptides on iminune responses were investigated. It was found that β-endorphin (β-END) can depress proliferative responses to PHA in rat splenocytes but enhance those in mice, and it could also inhibit the plaque-forming cell (PFC) response to sheep red blood cells when mouse splenocytes immunized in vivo were cultured in vitro with the peptide. The peptide antagonist naloxone was able to reverse β-END suppression of the PFC response. The data indicate that β-END suppresses antibody production or secretion via a specific opioidreceptor-mediated mechanism.

Effects of Peripherally Acting Opioid Ligands on Central Opioid Receptors and <i>β</i>-Endorphin Release in Stressed Rats

Using the radioreceptor binding assay, μ-opioid receptor (MOR) affinity in the midbrain of stressed rats was higher than in naive controls. MOR density in the rat frontal cortex was reduced after stress. Intragastric administration of the MOR antagonist naloxone methiodide was followed by an increase in the number of MORs in the frontal cortex. However, the MOR agonist loperamide significantly decreased the density of MORs in the frontal cortex and midbrain of naive animals. Loperamide and naloxone methiodide were shown to prevent an increase in MOR affinity and a decrease in MOR density in the midbrain of rats after restraint stress. The restraint stress was accompanied by an increase in the release of β-endorphin (BE) in the ventral tegmental area (VTA) of control rats. After administration, loperamide slightly decreased the release of BE, naloxone methiodide significantly increased the release of BE in the cingulate cortex (CC) of untreated animals, while drugs had no effect on the release of BE in the VTA. The drugs significantly increased the extracellular level of BE in the CC of stressed animals. Loperamide abolished the increase in the stress-induced release of BE in the VTA. By contrast, naloxone methiodide significantly increased the release of BE in the VTA of stressed rats. Our data indicated that activation of peripheral MORs induces depression of the central part of the μ-opioid system, but suppression of peripheral MOR activity induces activation of the central μ-opioid system, the interaction of which can be modulated by stress.

Plasma β-Endorphin Levels in Women with Early Threatened Abortion before and after the Treatment of Integrated Chinese and Western Medicine

To observe plasm a β-endorphin (β-EP) and gonadotrophin releasing horm one (GnRH), hum an chorionic gonadotrophin (hCG), progesterone (P4) levelsin w om en w ith early threatened abortion and w ith a history of recurrent spontaneous abortions (RSA). Tw enty patientsw ith threatened abortion at7～8 w eeksof gestation w ere re- cruited, allof them had a history of 3 or m ore recurrentunexplained abortions. They w ere treated w ith psychologicalconsultation accompanied by traditionalChinese herbs. Blood samples w ere taken to m easure β-EP, GnRH, hCG and P4 levels by radioim - m unoassay (RIA). The treatm ents w ere continued till10～12 w eeks, blood w astaken during this period to compare changes in these peptides / horm ones. Tw enty norm al pregnantw om en at7～8 and 10～12 w eeksand 20 patientsw ith incompleteabortion at 10～12 w eeksw ererecruited for comparativestudies. Results: (1) In norm alpregnant w om en, plasm a β-EP, GnRH, hCGand P4 levelsat10～12 w eeksw ere significantly higher than thatat7～8 w eeks (P< 0.01). (2) In patients w ith threatened abortion and a history of RSA, plasm a β-EP levels at7～8 w eeks w ere significantly higher than those of norm al pregnantw om en (P< 0.01); on the contrary, plasm a GnRH, hCGand P4 levelsin these patientsw ere significantly low er than thosein norm alcases (P< 0.01). After treatm ent, 16 of the 20 patients succeeded in m aintaining their pregnancies, the levels of the four plasm a contents at10～12 w eeks w ere sim ilar to thosein norm alpregnantw om en (P> 0.05). (3) Plasm a β-EPlevelsin patientsw ith incomplete abortionsat10～12 w eeksw ere dram atically higher and GnRH, hCGand P4 levelsw ere low er than in norm alpregnantw om en (P< 0.01). β-EP m ightplay a role in the pathophysiology of spontaneousabortion.

The effect of low frequency electromagnetic field on plasma β-endorphin in human brain

The effect of electromagnetic field on plasma β endorphin in 30 patients with migraine were studied in the experiment. All subjects received a 20 minute repetitive transcranial magnetic stimulation (Frequency 10Hz, Average intensity 8mT) per time, and the total experiment lasted 20 times. Before and after the experiment, the EEG and plasma β endorphin were tested. The results show that the level of plasma β endorphin in patients blood increased significantly from (73.486±26.002)mg/ml to (116.934±67.592)mg/ml (p<0.01), and the EEG average magnitude of the migraine patients were improved obviously from 41.77μV to 47.42μV.

半胱胺对小鹅血浆中β-END和某些激素的影响

选用２４只二月龄的杂交鹅（川白×太湖），随机分成对照组（１２只）和试验组（１２只）。试验组于日粮中一次性添加半胱胺（１００ｍｇ／ｋｇ·ＢＷ）。处理后第三天从翅静脉采取血样。用ＲＩＡ双抗法测定其中的β－ＥＮＤ、ＩＧＦ－Ｉ和各种激素的含量。结果表明：试验组的ＳＳ含量较对照组低１９．６４％（Ｐ＜０．０５）、而ＧＨ、ＩＧＦ－Ｉ和β－ＥＮＤ含量较对照组分别高５０．００％（Ｐ＜０．０１）、６２．８０％（Ｐ＜０．０１）和４４．５５（Ｐ＜０．０５）；与对照组相比较，试验组的ＴＳＨ低３２．３２％（Ｐ＜０．０５），Ｔ４下降１４．７２％（Ｐ＞０．０５），而Ｔ３升高２６．８０％（Ｐ＜０．０１）。以上结果提示：半胱胺可能是通过降低鹅血液中ＳＳ含量，使β－ＥＮＤ、ＩＧＦ－Ｉ、ＧＨ和Ｔ３水平升高，从而促进了鹅的快速生长。

天灸对哮喘模型大鼠脑组织β-END、IL-1的影响

目的:研究脑组织β-END、IL-1在天灸防治哮喘模型大鼠中的作用。方法:70只雄性大鼠随机分为正常组、模型组、天灸潜伏期治疗组、天灸发作期治疗组、电针潜伏期治疗组、电针发作期治疗组、西药组。用卵蛋白(OVA)致敏来制备哮喘模型大鼠。免疫组化法检测脑组织β-END、IL-1。结果:模型组β-END、IL-1高于正常组(P<0.01),经治疗后均有所增加,且天灸潜伏期治疗组最高。结论:天灸能提高室旁核区β-END、IL-1,且与疗效相应,其机制尚需进一步研究。

酶制剂对成年鹅血液中IGF-I、β-END及某些激素含量的影响

14只装有长久性翅静脉瘘管的成年鹅 ,自身对照。饲以大麦 (占 45 % )基础日粮 ,试验期添加 0 1%的Biokyowa粗酶制剂。经血管瘘管采血 ,分离血浆 ,用RIA法测定其中激素含量。结果如下 :与对照期相比 ,粗酶制剂使血液中GH、IGF -I和 β -END的水平分别升高 32 2 2 % (P <0 0 5 )、70 73% (P <0 0 1)和 35 2 1% (P <0 0 1) ;T3 、T4 水平分别高 15 38% (P <0 0 5 )和 14 97% (P <0 0 5 ) ,T3 /T4 基本不变 ,TSH有升高的趋势。以上结果提示 ,粗酶制剂能影响成年鹅的神经内分泌 ,改变血液中生长和代谢激素的水平 ,从而调节机体的新陈代谢。

Effectiveness and safety of electroacupuncture analgesia in controlling intraoperative pain and hemodynamics during total thyroidectomy:A randomized controlled trial

Objective:To evaluate the effectiveness and safety of electroacupuncture in conjunction with additional medications in providing analgesia and stabilizing hemodynamic parameters during total thyroidectomy.Methods:This randomized controlled trial included 100 patients who underwent a total thyroidectomy between October 2022 and October 2023 at the Vietnam National Hospital of Acupuncture.The patients were randomized into two groups.The electroacupuncture analgesia(EA)group received EA stimulation at five acupuncture points:Hegu(LI 4),Neiguan(PC 6),Shuitu(ST 10),Quepen(ST 12),and Yifeng(SJ 17),while the control group received a bilateral superficial cervical plexus block.Primary outcomes included the level of analgesia and perioperative vital signs in both groups.Additionally,pain thresholds and serum b-endorphin levels were measured before and after electroacupuncture in the EA group.Results:Complete analgesia(Level A)was attained in 86%and 76%of the patients in the EA and control groups,respectively,with no significant difference between the two groups(P=1.00).In the EA group,the mean pain threshold after receiving EA doubled(648.7(77.4)g/s vs.305.3(45.3)g/s,P<.001),and the mean serum b-endorphin level increased by approximately 13.5 pg/mL(P<.001).All patients remained hemodynamically stable throughout the surgery.Conclusion:EA,in conjunction with additional medications that stimulate five acupuncture points,LI 4,PC 6,ST 10,ST 12,and SJ 17,was well tolerated and effectively maintained a suitable level of analgesia and hemodynamic stability during total thyroidectomy.

激光穴位照射对子宫卵巢病牛血浆β-内啡肽含量和发情的影响

３４头黑白花奶牛，患子宫炎或卵巢疾病而不孕，将其随机分为２组。激光组（２４头）用Ｈｅ－Ｎｅ激光照射交巢穴，７ｄ为１疗程。间歇７ｄ再照射第２疗程。对照组（１０头）不用激光照射。ＲＩＡ法分析血浆β－内啡肽（β－ＥＮＤ）含量。结果发现，激光组病牛血浆β－ＥＮＤ由照射前（第０天）的１１２．８６４±５８．９４７ｐｇ／ｍｌ升高到第１疗程后（第８天）的１７５．６３４±１０４．３１０ｐｇ／ｍｌ（Ｐ＜０．０５），间歇１周后为（第１４天）２３７．６２７±１５３．１３６ｐｇ／ｍｌ（Ｐ＜０．０１），第２疗程后（第２２天）为１９３．４４８±１０４．３７８ｐｇ／ｍｌ（Ｐ＜０．０５）。显著高于对照组同期测定值。同时观察到，激光组发情牛头数为２１头，发情率８７．５％；对照组发情３头，发情率３０％。组间差异显著（Ｐ＜０．０１）。表明激光照射穴位可使病牛β－ＥＮＤ分泌增加。

孪生处理前后母牛在发情期的外周血中β－END含量测定

孪生处理前后母牛在发情期的外周血中β－ＥＮＤ含量测定杨利国，韩正康，李宁（南京农业大学畜牧系；动物医学学院，南京２１００９５）在黄牛人工孪生和超数排卵技术中，目前存在的主要问题是超排反应的个体差异较大。为了解决这一技术难关，国内外对超数排卵处理后的母...

四生汤抗放射反应作用机制的实验研究

在临床研究中,已经发现四生汤具有抗放疗毒副反应,提高机体免疫功能的作用,为了进一步探索该方的作用机理.我们以60Co 照射大鼠为实验对象,较系统地观察了四生汤对模型动物神经内分泌免疫网络内各不同层次,不同环节的影响及对照射大鼠下丘脑β-内啡肽含量的影响。

β-内啡肽对胶原诱导关节炎大鼠的免疫调节作用

目的研究β-内啡肽（β-END）对胶原诱导性关节炎（CIA）大鼠的免疫调节作用。为探索β-END治疗类风湿关节炎（RA）提供实验依据。方法采用尾根部皮内多点注射天然Ⅱ型胶原（CⅡ）的方法免疫雌性Wistar大鼠（60只）。建立CIA模型。随机取CIA成模大鼠（5只／组）于初次免疫后第14-35天。给予不同浓度的β-END腹腔内注射，定期进行临床、实验室、影像学及病理指标评估。结果不同剂量β-END（0．1、1、5nmol隔日1次共2周）治疗后CIA大鼠临床、实验室、影像学及病理指标明显缓解；正常鼠β-ENO给药5nmol×2周后重要脏器功能、组织学未见明显异常。结论生理浓度的β-END体内可缓解CIA鼠关节局部及全身免疫炎性反应。这使β-END成为有潜力的治疗RA的制剂。

Effects of Repeated Electroacupuncture on β-Endorphin and Adrencorticotropic Hormone Levels in the Hypothalamus and Pituitary in Rats with Chronic Pain and Ovariectomy

Objective： To explore the mechanism of electroacupuncture （EA）-induced cumulative analgesic effects on chronic pain in rats with or without ovariectomy （OVX）. Methods： A total of 110 female Wistar rats were randomized into normal control （n=10）, chronic constrictive injury （CCI, n=10）, CCI＋EA （n=30）, OVX＋CCI （n=30）, and OVX＋CCI＋EA （n=30） groups. Each of the latter 3 groups was further divided into 2 days （2 d）, 2 weeks （2 W） and 3 weeks （3 W） subgroups, respectively （n=10 in each subgroup）. The CCI pain model was established by ligature of the right sciatic nerve, and the memory impairment model duplicated by OVX. The paw withdrawal latency （PWL, pain threshold） of the bilateral footplates was detected by radiant heat irradiation, and the bilateral difference in PWL （PWLD） was used to evaluate changes in the pain reaction. Morris water maze test was conducted for evaluating the rats＇ learning-memory ability. EA was applied to bilateral Zusanli （ST36） and Yanglingquan （GB34） for 2 d, 2 W and 3 W, respectively. Pituitary and hypothalamic 13-endorphin （EP） and adrenocorticotrophic hormone （ACTH） contents were detected by immunoradioassay. Results： Compared with the CCI group, PWLD of the CCI＋EA-3 W group decreased significantly （P〈0.05）. Compared with the OVX＋CCI group, PWLD of the OVX＋CCI＋EA-3 W group was lowered considerably （P〈0.05）, but the value was markedly higher than its basal value and those of the normal control and CCI＋EA groups （P〈0.05）. In comparison with the sham-OVX group, the escape latency, swimming distance （SD） in the target quadrant and total SD were increased remarkably in the OVX group （P〈0.05）, while the number of target platform crossings was decreased significantly （P〈0.05）, suggesting an impairment of the OVX rats＇ learning-memory ability. In simple CCI rats, both β-EP and ACTH contents of the pituitary increased markedly （P〈0.05）, and those of the hypothalamus decreased obviously compared to the normal control group （P〈0.05）. After EA, pituitary and hypothalamic ACTH levels were significantly lowered at 2 d and hypothalamic ACTH and β -EP contents increased obviously at 3 W in comparison with the CCI group （P〈0.05）. In OVX＋CCI rats, following EA, pituitary β -EP contents at 2 d, 2 W and 3 W, and hypothalamic β-EP and ACTH contents at 2 W and hypothalamic ACTH levels at 3 W increased significantly （P〈O.05）, but hypothalamic β-EP level at 3W decreased markedly （P〈0.05）. The effects of repeated EA in lowering pituitary ACTH and raising hypothalamic β-EP and ACTH levels disappeared after OVX＋CCI. Conclusions： Repeated EA has a cumulative analgesic effect, which is closely associated with its effects in regulating pituitary and hypothalamic β-EP and ACTH levels. OVX may weaken the analgesic effect of EA by affecting hypothalamic-pituitary axis activity.

Study on Therapeutic Mechanism of Neiyifang (内异方) in Treating Endometriosis

Objective: To observe the clinical effect of Neiyifang (内异方,NYF) in treating endometri-osis and to explore its therapeutic mechanism through observing its influence on plasma β-endorphin β-EP) in different menstrual stages and levels of prostaglandins (PGs) in menstruation. Methods: NYF was administered to 104 patients with endometriosis one dose daily with 3 successive menstrual cycles as one therapeutic course. Peripheral blood β-EP level in follicular, luteal and menstrual stages, as well as PGF2a, PGE2, thromboxane B2 and 6-keto-PGF1a levels in menstrual stage were detected by RIA, and controlled with those in 15 healthy persons. Results: (1) The total effective rate of NYF was 81. 3% and it showed significant effect in improving patients' clinical symptoms and physical signs; (2) In menstrual stage, the levels of β-EP, 6-keto-PGF1α/ TXB2 were lower(P<0.05) and levels of PGF2a, PGE2, TXB2 and 6-keto-PGF1α, were higher (P<0. 05) in patients than those in control, and the higher the level of PGE2, the severer the menalgia, (3) NYF could increase levels of β-EP, 6-keto-PGF1α, and reduce levels of PGF2α, PGE2 in menstrual stage of patients (all P<0.05). Conclusion: (1) NYF has good clinical effect in treating endometriosis, (2) Patients' symptom of menalgia is closely related with the excessive high levels of PGF2a and PGE2 PGI2/TXA2 ratio disturbance, and excessive low level of β-EP; (3) NYF could significantly decrease the PGE2, PGF1a levels, increase the 6-keto-PGF1a/TXB2 ratio and the level of β-EP, so as to alleviate the menalgia in patients with endometriosis.

Study on the Analgesic Effect and Mechanism of Zhitong Capsule (止痛胶囊) in Adjuvant Arthritis Rats

Objective: To observe the analgesic effect of Zhitong Capsule (止痛胶囊, ZTC) and study its mechanism in adjuvant arthritis (AA) rats. Methods: Forty-eight male Sprague-Dawley rats were randomly divided into six groups with 8 rats in each group. On the first day, except to those in the normal group that were treated with normal saline, the same amount of Freund's complete adjuvant (FCA) was given through intradermal injection into the right hind paw to all the rats in the other groups. From the 17th day of the modeling on, the rats in groups of ZTC were administered daily through gastrogavage with a dose of 1000, 500, 250 mg/kg respectively, while equal volume of normal saline was given to those in the normal group and model group, and an equal volume of aspirin (ASA) solution was given to rats in the ASA group through gastrogavage for 10 days, once per day, and on the 27th day, the analgesic effect of ZTC was measured with heat withdraw method. The activities and contents of superoxide dismutase (SOD) and lipid peroxides (LPO) in serum were observed by spectrophotometry, and the level of beta-endorphin (β-EP) in hypothalamus were determined by the assay of immunohistochemistry. Results: ZTC showed significant effects on enhancing the pain threshold and at the same time it increased the activities of SOD and reduced the contents of LPO in serum. ZTC could also increase the level of β-EP in hypothalamus. Conclusion: ZTC has analgesic effect and its mechanism is probably related with its effect in inhibiting the level of oxygen free radicals in serum and increasing the level of β-EP of hypothalamus in rats.KEY WORD Zhitong Capsule, adjuvant arthritis, superoxide dismutase, lipid peroxides, β-endorphin

Optimal compatible doses and effects of ephedrine and naloxone on neural plasticity in cerebral ischemia/reperfusion rats

BACKGROUND： Ephedrine promotes neural plasticity in rats following cerebral ischemia/reperfusion injury. Ephedrine has been combined with naloxone in some studies, and it has been confirmed that their combination has synergistic effects on increasing neural plasticity following cerebral ischemia/reperfusion injury. OBJECTIVE： To investigate the effects of ephedrine combined with various doses of naloxone on neural plasticity and to find an optimal dose of naloxone in rats after cerebral ischemia/reperfusion injury by analyzing growth associated protein-43 （GAP-43）, synaptophysin and β-endorphin expression in the hippocampal CA3 area. DESIGN, TIME AND SETTING： This immunohistochemical, randomized, controlled, animal experiment was performed at the Chongqing Research Institute of Pediatrics, China from September 2007 to June 2008. MATERIALS： Ephedrine hydrochloride injection and naloxone hydrochloride injection were respectively purchased from Shandong Lvliang Pharmaceutical Factory, China and Sichuan Jingwei Pharmaceutical Co., Ltd., China. A total of 192 healthy adult Sprague Dawley rats were used to establish models of left middle cerebral artery occlusion using the suture occlusion method. METHODS： At 2 hours following cerebral ischemia, the rats were intraperitoneally injected with 1.5 mg/kg/d ephedrine （ephedrine group）, with 0.1, 0.2, or 0.3 mg/kg/d naloxone （low, moderate and high doses of naloxone groups）, with 1.5 mg/kg/d ephedrine ＋ 0.1, 0.2, or 0.3 mg/kg/d naloxone （ephedrine ＋ low, moderate and high doses of naloxone groups）, and with 0.5 mL saline （model group）, respectively. MAIN OUTCOME MEASURES： GAP-43, synaptophysin and β -endorphin expression were detected in the hippocampal CA3 area using immunohistochemistry 1-4 weeks after surgery. Sensorimotor integration in rats was assessed using the beam walking test. RESULTS： GAP-43 and synaptophysin expression was greater in the ephedrine group, and in the ephedrine ＋ moderate and high doses of naloxone groups compared with the model group. GAP-43 and synaptophysin expression was greatest in the ephedrine ＋ high dose of naloxone group at 2 and 3 weeks alter surgery. β -endorphin expression was significantly lower in the ephedrine group, and in the ephedrine ＋ moderate and high doses of naloxone groups compared with the model group （P 〈 0.05）. β -endorphin expression was persistently low in the ephedrine ＋ high dose of naloxone group. At 1-3 weeks after surgery, the beam walking test score was significantly higher in the ephedrine group and ephedrine ＋ various doses of naloxone groups than in the model group （P 〈 0.05）. The score was higher in the ephedrine ＋ moderate and high doses of naloxone groups than in the ephedrine group （P 〈 0.05）. Moreover, the score was increased as the dose of naloxone increased in the ephedrine ＋ various doses of naloxone groups. CONCLUSION： Ephedrine promotes GAP-43 and synaptophysin expression, inhibits /3 -endorphin expression in the hippocampal CA3 area, and improves motor function in rats following cerebral ischemia/reperfusion injury. Naloxone does not have the above-mentioned effects. During combined treatment with ephedrine and naloxone, however, the above-described effects are enhanced with an increased dose of naloxone. The combination of ephedrine （1.5 mg/kg/d） and naloxone （0.3 mg/kg/d） can produce optimal therapeutic efficacy in treatment of cerebral ischemic injury.

Synchrony between Ovarian Function &Sleep in Polycystic Ovary Syndrome Patients

Polycystic ovary syndrome (PCOS) is a complex, multifaceted, heterogeneous disorder, affecting 4% to 18% of reproductive-aged women and is associated with reproductive, metabolic and psychological dysfunction. In this study we determined the relationship between the time to sleep and serum levels of neurohormones in polycystic ovary syndrome (PCOS). Totally 77 PCO patients(case group) and 97 non-PCOS infertile women (control subjects) participated in this study between February 2012 and February 2013. A PSQI sleep questionnaire was completed by each patient in both groups. PSQI sleep questionnaire score and serum concentration of adrenaline, noradrenaline, melatonin, β-endorphin, cortisol and progesterone were compared in two groups. The results of the study indicate that serum levels of melatonin and β-endorphin were lower in women with PCOS. Serum level of stress hormones, adrenaline and noradrenaline were significantly correlated with patients’ sleep time in study group. Serum level of adrenaline in control group was significantly lower in women who wake up earlier in the morning. All hormones except for cortisol had no significant correlation with PSQI global score in both groups and also the people who sleep less than 8 hours had lower cortisol level. These data showed that changes in cortisol in PCO women were due to damage of disturbed sleep at night. Our preliminary work provided this study with new insight into the interactions between sleep-wake cycles in PCO women with specific sleep patterns.